Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
about
Targeted Radionuclide Therapy of Human TumorsImpact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.Characterization of Cardiac Glycoside Natural Products as Potent Inhibitors of DNA Double-Strand Break Repair by a Whole-Cell Double Immunofluorescence Assay.Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma.Clinical research on rare diseases of children: neuroblastoma.Advances in emerging drugs for the treatment of neuroblastoma.Harnessing Solute Carrier Transporters for Precision Oncology.Targeting of PHOX2B expression allows the identification of drugs effective in counteracting neuroblastoma cell growth.Norepinephrine Transporter as a Target for Imaging and Therapy.Neuroblastoma: clinical and biological approach to risk stratification and treatment.Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
P2860
Q26771267-08D572E1-16FB-4D02-AD3E-4B5BFB3934E1Q33427090-02335914-40FD-4C20-9958-EE8F82005DC6Q33428982-49C634E4-4381-4828-9047-AAF507C86513Q35940003-C9F586CB-F676-40CA-9064-B8ACB5B20CD6Q36167173-AB06EAA4-6C80-40C0-8F0A-652195E3B9C8Q37625678-013A05D8-29C3-4F31-BE0C-C807BA255F14Q38791761-999824BC-A586-40AC-A8B9-EAB0C94FC76BQ39158415-C14CD70C-B20F-4388-A749-595224F80173Q39204754-5554DD17-6032-498E-8AE6-E197122AE04EQ42700826-CA016A57-32A9-4941-AD93-B99933A29FE7Q47867820-387852EB-4A61-4144-AD63-0914FC3C66A5Q52639269-DA9C07AA-B53F-4085-B552-E9465795BE17Q52722728-88E1F60D-20E1-4E9B-A8E3-CD4BBB7EEC50
P2860
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@ast
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@en
type
label
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@ast
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@en
prefLabel
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@ast
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@en
P2093
P2860
P1476
Phase I Study of Vorinostat as ...... ed or Refractory Neuroblastoma
@en
P2093
Araz Marachelian
Brian Weiss
Daphne A Haas-Kogan
Denice Tsao-Wei
Ethan Geier
Eugene Chen
Fariba Goodarzian
Gregory A Yanik
Hiroyuki Shimada
Hollie Jackson
P2860
P304
P356
10.1158/1078-0432.CCR-14-3240
P407
P577
2015-02-18T00:00:00Z